BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10949582)

  • 1. Cellular turnover and extracellular matrix remodeling in female reproductive tissues: functions of metalloproteinases and their inhibitors.
    Fata JE; Ho AT; Leco KJ; Moorehead RA; Khokha R
    Cell Mol Life Sci; 2000 Jan; 57(1):77-95. PubMed ID: 10949582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian tissue remodeling: role of matrix metalloproteinases and their inhibitors.
    Smith MF; Ricke WA; Bakke LJ; Dow MP; Smith GW
    Mol Cell Endocrinol; 2002 May; 191(1):45-56. PubMed ID: 12044918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of TIMPs in regulation of extracellular matrix proteolysis.
    Arpino V; Brock M; Gill SE
    Matrix Biol; 2015; 44-46():247-54. PubMed ID: 25805621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle.
    Curry TE; Osteen KG
    Endocr Rev; 2003 Aug; 24(4):428-65. PubMed ID: 12920150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen-induced alterations in the expression of selected matrix metalloproteinases (MMP-2, -9, -10, and -13) and their tissue inhibitors (TIMP-2 and -3) in the chicken ovary.
    Wolak D; Hrabia A
    Theriogenology; 2020 May; 148():208-215. PubMed ID: 31753476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases in tumor invasion.
    Johansson N; Ahonen M; Kähäri VM
    Cell Mol Life Sci; 2000 Jan; 57(1):5-15. PubMed ID: 10949577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of matrix metalloproteinases in melanoma cell invasion.
    Hofmann UB; Houben R; Bröcker EB; Becker JC
    Biochimie; 2005; 87(3-4):307-14. PubMed ID: 15781317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TIMPs and cardiac remodeling: 'Embracing the MMP-independent-side of the family'.
    Vanhoutte D; Heymans S
    J Mol Cell Cardiol; 2010 Mar; 48(3):445-53. PubMed ID: 19799912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic changes in the matrix metalloproteinase system in the ovary and uterus.
    Curry TE; Osteen KG
    Biol Reprod; 2001 May; 64(5):1285-96. PubMed ID: 11319131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix-metalloproteinases 1, 2, and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization study.
    Brummer O; Athar S; Riethdorf L; Löning T; Herbst H
    Virchows Arch; 1999 Dec; 435(6):566-73. PubMed ID: 10628798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MMPs and TIMPs expression in facial tissue of children with cleft lip and palate.
    Smane-Filipova L; Pilmane M; Akota I
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Dec; 160(4):538-542. PubMed ID: 27876897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases and their tissue inhibitors in the developing neonatal mouse uterus.
    Hu J; Zhang X; Nothnick WB; Spencer TE
    Biol Reprod; 2004 Nov; 71(5):1598-604. PubMed ID: 15240428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinase-3 and -4 in normal ovary and ovarian carcinoma.
    Ripley D; Tunuguntla R; Susi L; Chegini N
    Int J Gynecol Cancer; 2006; 16(5):1794-800. PubMed ID: 17009974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes.
    Fata JE; Werb Z; Bissell MJ
    Breast Cancer Res; 2004; 6(1):1-11. PubMed ID: 14680479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human fetal testis and ovary.
    Robinson LL; Sznajder NA; Riley SC; Anderson RA
    Mol Hum Reprod; 2001 Jul; 7(7):641-8. PubMed ID: 11420387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression and localization of selected matrix metalloproteinases (MMP-2, -7 and -9) and their tissue inhibitors (TIMP-2 and -3) in follicular cysts of sows.
    Grzesiak M; Kaminska K; Knapczyk-Stwora K; Hrabia A
    Theriogenology; 2022 Jun; 185():109-120. PubMed ID: 35395587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue inhibitor of metalloproteinases-4. The road less traveled.
    Melendez-Zajgla J; Del Pozo L; Ceballos G; Maldonado V
    Mol Cancer; 2008 Nov; 7():85. PubMed ID: 19025595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of matrix metalloproteinases during stimulated ovarian recrudescence in Siberian hamsters (Phodopus sungorus).
    Salverson TJ; McMichael GE; Sury JJ; Shahed A; Young KA
    Gen Comp Endocrinol; 2008 Feb; 155(3):749-61. PubMed ID: 17980368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
    Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE
    Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.